Company Filing History:
Years Active: 1992-1993
Title: Innovations in Melanoma Vaccines by Inventor Sridhar Pennathur
Introduction
Sridhar Pennathur is an accomplished inventor based in Seattle, WA, specializing in the development of innovative vaccine formulations. With a focus on melanoma treatment, he holds two patents that contribute significantly to the field of immunology and cancer therapy.
Latest Patents
Pennathur's latest patents revolve around the creation of recombinant viruses encoding human melanoma-associated antigens. These patents describe peptides or proteins that can be produced in large quantities using recombinant DNA techniques or chemical synthetic methods. The technology is designed to utilize these peptides or proteins as immunogens in vaccine formulations, aiming to induce an immune response that selectively targets and destroys melanoma cells in vaccinated individuals. The patents also detail how these peptides can be expressed by a recombinant virus, allowing for the preparation of either inactivated or live virus vaccine formulations, enhancing the potential for effective melanoma vaccines.
Career Highlights
Throughout his career, Sridhar Pennathur has contributed to advancements in cancer treatment through his innovative approaches to vaccine development. He works at Oncogen, where his expertise in recombinant DNA techniques and immunology has helped to propel the company's research initiatives forward. His commitment to fighting melanoma and advancing cancer therapy is evident in his work and the patents he has secured.
Collaborations
Pennathur collaborates with notable colleagues such as Joseph P. Brown and Charles D. Estin. These professional partnerships are instrumental in driving research efforts and developing cutting-edge solutions in the fight against melanoma. Together, they are making significant strides in the field of immunology.
Conclusion
As an inventor, Sridhar Pennathur is making remarkable contributions to the realm of melanoma vaccines. His innovative solutions and collaborative efforts at Oncogen position him as a key figure in advancing cancer treatment through scientific discovery and patent protection. The patents he holds not only reflect his dedication to the field but also pave the way for future advancements in immunotherapy.